Key result
Low basal renin-angiotensin system activity was associated with a slightly more pronounced QT prolongation during hypoglycaemia compared to high activity (6 ± 3 ms difference, P=0.04).
Why the study?
Does basal RAS activity affect cardiac repolarization during hypoglycaemia in patients with type 1 diabetes?
RCT (n=18)
Single-blind
Does basal RAS activity affect cardiac repolarization during hypoglycaemia in patients with type 1 diabetes?
p-value: p=0.04
Low basal RAS activity may modestly increase QT prolongation during hypoglycaemia in type 1 diabetes, though its clinical impact on arrhythmia risk remains unclear.
Low basal RAS activity may modestly heighten hypoglycemia-related QT prolongation in T1D; leaves open arrhythmia risk and needs prospective validation.
AIMS: Hypoglycaemia-induced cardiac arrhythmias may be involved in the pathogenesis of the 'dead-in-bed syndrome' in patients with type 1 diabetes. Evidence suggests that the renin-angiotensin system (RAS) influences the occurrence of arrhythmias. The aim of this study was to explore if basal RAS activity affects cardiac repolarization during hypoglycaemia, thereby potentially carrying prognostic information on risk of the 'dead-in-bed syndrome'. METHODS AND RESULTS: Nine subjects with high RAS activity and nine subjects with low RAS activity were subjected to single-blinded placebo-controlled hypoglycaemia (nadir plasma glucose 2.4 mmol/L). QTc/QTcF and QT dynamics were registered by Holter monitoring. QTc prolonged during [8 (+/-2.3) ms, P < 0.01] and after [11 (+/-3) ms, P < 0.001] hypoglycaemia. Dynamic QT parameters reacted ambiguously. Low RAS activity was associated with a slightly more pronounced QT prolongation [6 (+/-3) ms, P = 0.04]. Adrenaline tended to increase more in the low-RAS group (P = 0.08) and was correlated to QTc (r = 0.67, P < 0.01) and QTcF (r = 0.58, P < 0.05) during hypoglycaemia. CONCLUSION: Low basal RAS activity may be associated with a slightly more pronounced QT prolongation during hypoglycaemia, when compared with high RAS activity. The impact, however, is modest and the clinical consequence is unclear.
No takes yet. Share an insight, caveat, or question.
Due-Andersen et al. (2008) conducted an RCT in Type 1 diabetes (n=18). Low basal renin-angiotensin system (RAS) activity vs. High basal RAS activity was evaluated on QTc prolongation during hypoglycaemia (p=0.04). Low basal renin-angiotensin system activity was associated with a slightly more pronounced QT prolongation during hypoglycaemia compared to high activity (6 ± 3 ms difference, P=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: